Tag: iPS Cells
-
iPS Cells and the Future of Parkinson’s Treatment: Bridging the Gap Between Innovation and Accessibility
🏁 [Overview] Technical Breakthrough vs. Economic Reality The landscape of regenerative medicine is shifting rapidly. Recent reports from Japan’s Sankei News highlight a significant milestone: iPS cell-based therapy for Parkinson’s disease, developed by Kyoto University and Sumitomo Pharma, is nearing commercial approval. While the scientific community celebrates this “cure,” we must ask a critical question…